KL
ABBV icon

KWMG LLC’s AbbVie ABBV Stock Holding History

KWMG LLC’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$352K Hold
1,397
– – 0.03% 130
2026
Q1 		$304K Sell
1,397
-15
-1% -$3.33K 0.03% 132
2025
Q4 		$323K Buy
1,412
+40
+3% +$9.11K 0.03% 133
2025
Q3 		$318K Hold
1,372
– – 0.03% 132
2025
Q2 		$255K Hold
1,372
– – 0.02% 139
2025
Q1 		$287K Buy
1,372
+128
+10% +$24.9K 0.03% 132
2024
Q4 		$221K Hold
1,244
– – 0.02% 136
2024
Q3 		$246K Hold
1,244
– – 0.02% 129
2024
Q2 		$213K Hold
1,244
– – 0.02% 130
2024
Q1 		$227K Buy
+1,244
New +$214K 0.02% 126
2023
Q2 		– Sell
-1,365
Closed -$218K – 136
2023
Q1 		$218K Buy
1,365
+97
+8% +$14.8K 0.03% 136
2022
Q4 		$205K Buy
+1,268
New +$194K 0.03% 136
2019
Q2 		– Sell
-976
Closed -$79K – 115
2019
Q1 		$79K Sell
976
-77
-7% -$6.3K 0.02% 149
2018
Q4 		$97K Sell
1,053
-87
-8% -$7.65K 0.03% 127
2018
Q3 		$108K Sell
1,140
-109
-9% -$10.3K 0.03% 123
2018
Q2 		$116K Sell
1,249
-19,686
-94% -$1.92M 0.03% 118
2018
Q1 		$1.98M Sell
20,935
-5,990
-22% -$658K 0.58% 54
2017
Q4 		$2.6M Buy
26,925
+404
+2% +$38.1K 0.78% 26
2017
Q3 		$2.36M Buy
26,521
+1,561
+6% +$119K 0.78% 29
2017
Q2 		$1.81M Buy
24,960
+1,797
+8% +$121K 0.64% 39
2017
Q1 		$1.51M Buy
23,163
+3,811
+20% +$240K 0.58% 58
2016
Q4 		$1.21M Buy
19,352
+4,497
+30% +$274K 0.53% 59
2016
Q3 		$937K Buy
14,855
+1,611
+12% +$104K 0.46% 66
2016
Q2 		$820K Buy
+13,244
New +$807K 0.44% 68

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

KWMG LLC's ABBV Position: Q2 2026 in Review

KWMG LLC held its AbbVie (ABBV) position steady in Q2 2026 at 1,397 shares worth $352K. The position accounts for 0.03% of the portfolio, ranked #130.

KWMG LLC first reported a position in ABBV in Q2 2016 and has held it in 24 quarters since. The position peaked at $2.6M in Q4 2017. 4,192 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • KWMG LLC held 1,397 shares of AbbVie worth $352K as of Q2 2026.
  • KWMG LLC left its AbbVie share count unchanged in Q2 2026.
  • AbbVie made up 0.03% of KWMG LLC's portfolio in Q2 2026, its #130 holding.
  • KWMG LLC first reported a position in AbbVie in Q2 2016 and has held it in 24 quarters since.
  • KWMG LLC's AbbVie position peaked at $2.6M in Q4 2017.
  • 4,192 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on KWMG LLC's 13F filing for Q2 2026, filed 8 Jul 2026.